Maintenance therapy with Everolimus in patients with tuberous sclerosis successfully treated for subependymal giant cell astrocytoma - EMINENTS (Everolimus MaINtENance Therapy in SEGA)

Trial Profile

Maintenance therapy with Everolimus in patients with tuberous sclerosis successfully treated for subependymal giant cell astrocytoma - EMINENTS (Everolimus MaINtENance Therapy in SEGA)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Tuberous sclerosis
  • Focus Therapeutic Use
  • Acronyms EMINENTS
  • Most Recent Events

    • 15 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top